CR

Corey Ritter

ARCH Venture Partners

Greater Chicago Area

Overview 

Corey Ritter is a Principal at ARCH Venture Partners, with a background in special operations and interagency coordination in Afghanistan. He has successfully invested in startups like Slingshot Biosciences at the Series A stage, focusing on sectors such as diagnostics, robotics, and biotech in the Midwest region.

Work Experience 

  • Board Member

    2025 - Current

  • Partner

    2017

    ARCH creates and invests in companies commercializing disruptive life and physical science technologies.

ARCH is a venture firm that focuses on life science discoveries to prevent, detect, and cure disease.

  • Board Member

    2021

    Superconducting quantum computing. Pursuing fault-tolerance by solving the most important problem in quantum computing: error correction.

Quantum Circuits is developing and commercializing quantum computing technology that utilizes superconducting quantum circuits.

Raised $78,000,000.00 from F-Prime Capital, Tribeca Venture Partners, Fitz Gate Ventures, Hither Creek Ventures, Canaan Partners, Sequoia Capital, ARCH Venture Partners, IQT, Connecticut Innovations and OUP (Osage University Partners).

  • Board Member

    2021

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

Raised $49,227,275.00 from Northpond Ventures, Anterra Capital, ARCH Venture Partners, Northpond Ventures, ARCH Venture Partners and Anterra Capital.

  • Board Member

    2022

Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.

Raised $123,500,000.00 from Venture Investors, TAO Investments, State of Wisconsin Investment Board, WARF Ventures, Sands Capital Ventures, ARCH Venture Partners, Northpond Ventures and Moore Strategic Ventures.

  • Board Member

    2024

  • Board Observer

    2019

    Company creation, founding; led Series A financing.

Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.

Raised $136,200,000.00 from ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.

  • Board Observer

    2019

    Company creation, founding; led Series A financing.

Scale Biosciences is a single-cell profiling and analysis solutions company for genomic, transcriptomic, and multi-omic applications.

  • Board Observer

    2018 - 2021

    NASDAQ: MASS

908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.

Raised $167,800,000.00 from Northpond Ventures, Saudi Aramco Energy Ventures, Razor's Edge Ventures, Tao Capital Partners, Casdin Capital, SLB, Sands Capital Ventures and ArchVentures SA.

  • George Schultz Innovation Fund Associate

    2017 - 2017

    The Innovation Fund invests in science-based startups emanating from U Chicago & Argonne National Lab.

Articles About Corey

Relevant Websites